Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1241 - 1248 of 11616 results
SEC Adopts New Share Repurchase Disclosure Rules
May 18, 2023| Alert| Viewpoint
IRS Provides Initial Guidance on Made in America Rules for Clean Energy Tax Credits
May 18, 2023| Alert| Viewpoint
Get To Know An FCBA MEMBER
May 18, 2023| News
Justices’ Denial Of CWA Citizen Suit Petition Could Shape State Enforcement
May 18, 2023| News
Clients Embrace Litigation Finance To Cut Costs In Tough Economy
May 18, 2023| News
Eligibility for United States Citizenship
May 17, 2023| Resources| Viewpoint
Emerging Managers Shouldn’t Rush A First Close – Even In This Market
May 17, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.